197 related articles for article (PubMed ID: 35865483)
1. Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma
Basu R; Qian Y; Mathes S; Terry J; Arnett N; Riddell T; Stevens A; Funk K; Bell S; Bokal Z; Batten C; Smith C; Mendez-Gibson I; Duran-Ortiz S; Lach G; Mora-Criollo PA; Kulkarni P; Davis E; Teaford E; Berryman DE; List EO; Neggers S; Kopchick JJ
Front Oncol; 2022; 12():936145. PubMed ID: 35865483
[TBL] [Abstract][Full Text] [Related]
2. Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps.
Basu R; Baumgaertel N; Wu S; Kopchick JJ
Horm Cancer; 2017 Jun; 8(3):143-156. PubMed ID: 28293855
[TBL] [Abstract][Full Text] [Related]
3. Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.
Basu R; Kulkarni P; Qian Y; Walsh C; Arora P; Davis E; Duran-Ortiz S; Funk K; Ibarra D; Kruse C; Mathes S; McHugh T; Brittain A; Berryman DE; List EO; Okada S; Kopchick JJ
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31547367
[TBL] [Abstract][Full Text] [Related]
4. Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.
Qian Y; Basu R; Mathes SC; Arnett NA; Duran-Ortiz S; Funk KR; Brittain AL; Kulkarni P; Terry JC; Davis E; Singerman JT; Henry BE; List EO; Berryman DE; Kopchick JJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291663
[TBL] [Abstract][Full Text] [Related]
5. Dose-response effects of a new growth hormone receptor antagonist (B2036-PEG) on circulating, hepatic and renal expression of the growth hormone/insulin-like growth factor system in adult mice.
van Neck JW; Dits NF; Cingel V; Hoppenbrouwers IA; Drop SL; Flyvbjerg A
J Endocrinol; 2000 Nov; 167(2):295-303. PubMed ID: 11054644
[TBL] [Abstract][Full Text] [Related]
6. Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice.
Chen NY; Chen WY; Kopchick JJ
Endocrinology; 1997 May; 138(5):1988-94. PubMed ID: 9112397
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
[TBL] [Abstract][Full Text] [Related]
8. A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: potential impact of increased adiposity, leptin, and insulin with advancing age.
Berryman DE; Lubbers ER; Magon V; List EO; Kopchick JJ
J Gerontol A Biol Sci Med Sci; 2014 Feb; 69(2):131-41. PubMed ID: 23695394
[TBL] [Abstract][Full Text] [Related]
9. Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma.
Kaseb AO; Haque A; Vishwamitra D; Hassan MM; Xiao L; George B; Sahu V; Mohamed YI; Carmagnani Pestana R; Lombardo JL; Avritscher R; Yao JC; Wolff RA; Rashid A; Morris JS; Amin HM
Front Oncol; 2022; 12():986305. PubMed ID: 36276070
[TBL] [Abstract][Full Text] [Related]
10. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs.
Borel F; Han R; Visser A; Petry H; van Deventer SJ; Jansen PL; Konstantinova P;
Hepatology; 2012 Mar; 55(3):821-32. PubMed ID: 21932399
[TBL] [Abstract][Full Text] [Related]
11. Role of ATP-binding Cassette Transporters in Sorafenib Therapy for Hepatocellular Carcinoma: An Overview.
Estevinho MM; Fernandes C; Silva JC; Gomes AC; Afecto E; Correia J; Carvalho J
Curr Drug Targets; 2022; 23(1):21-32. PubMed ID: 33845738
[TBL] [Abstract][Full Text] [Related]
12. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.
Cuestas ML; Sosnik A; Mathet VL
Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727
[TBL] [Abstract][Full Text] [Related]
13. siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.
Zhou D; Yang J; Huang WD; Wang J; Zhang Q
World J Gastroenterol; 2013 Nov; 19(44):8108-13. PubMed ID: 24307807
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of growth hormone insensitivity.
Young J; Bell S; Qian Y; Hyman C; Berryman DE
Rev Endocr Metab Disord; 2021 Mar; 22(1):17-29. PubMed ID: 33037595
[TBL] [Abstract][Full Text] [Related]
15. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
16. Autocrine/paracrine actions of growth hormone in human melanoma cell lines.
Buckels A; Zhang Y; Jiang J; Athar M; Afaq F; Shevde-Samant L; Frank SJ
Biochem Biophys Rep; 2020 Mar; 21():100716. PubMed ID: 31890904
[TBL] [Abstract][Full Text] [Related]
17. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.
Coschigano KT; Holland AN; Riders ME; List EO; Flyvbjerg A; Kopchick JJ
Endocrinology; 2003 Sep; 144(9):3799-810. PubMed ID: 12933651
[TBL] [Abstract][Full Text] [Related]
18. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
[TBL] [Abstract][Full Text] [Related]
19. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice.
Dagnaes-Hansen F; Duan H; Rasmussen LM; Friend KE; Flyvbjerg A
Anticancer Res; 2004; 24(6):3735-42. PubMed ID: 15736405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
